Antibody Clinical Trials Genotoxicity Trials 
Pharmaceutical Technology
SEPTEMBER 10, 2008
NC: What are the most recent developments in your genotoxicity studies and which are proving most successful? IS: Our genotoxicity testing includes the core battery of the tests requested by EMEA/ICH including mutagenicity in vitro, chromosomal aberration test in vitro and micronucleus test in vivo.
The Pharma Data
APRIL 14, 2021
The FDA’s accelerated approval mechanism enables drugs that treat serious diseases with unmet medical need to be approved based on a surrogate or intermediate clinical endpoint. Continued approval is contingent upon verification and description of clinical benefit in a confirmatory trial. About Trodelvy.
Expert insights. Personalized for you.
130 
Let's personalize your content